Amphastar Pharmaceuticals, Inc. — Director's Dealing 2021

Nov 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2021-11-22

Reporting Person: PRINS RICHARD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-22	Common Stock	M	5000	$17.11	Acquired	50179	Direct
2021-11-22	Common Stock	S	5000	$21.22	Disposed	45179	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-22	Stock Option (right to buy)	$17.11	M	5000	Disposed	2022-06-08	Common Stock (5000)	Direct

Footnotes

F1: Shares subject to the option are fully vested and immediately exercisable.